Investec Bank Plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group Plc (AMS.L) under the UK Takeover Code.
The disclosure was filed on 4th September 2026, covering transactions that took place on 3rd September 2026 in the ordinary shares of Advanced Medical Solutions Group Plc.
Investec Bank Plc is acting as Advisor and Joint Broker to Advanced Medical Solutions Group Plc in connection with the relevant offer period.
The filing was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec, operating in a client-serving capacity, disclosed purchases of 14,380 ordinary shares at a price of 281.25 pence per unit during the relevant trading session.
In addition to the purchases, Investec also disclosed sales of 39,003 ordinary shares, also transacted at a price of 281.25 pence per unit.
Both the highest and lowest prices recorded for all transactions were identical at 281.25 pence, indicating the dealings were executed at a consistent single price point.
The disclosure confirmed that no cash-settled derivative transactions, stock-settled derivative transactions, or options were involved in the dealings reported for this period.
Investec also confirmed there are no indemnity arrangements, option arrangements, or formal and informal agreements relating to relevant securities that may act as an inducement to deal or refrain from dealing.
Similarly, no agreements, arrangements, or understandings relating to voting rights, options, or derivatives were reported as part of the submission filed by contact Abhishek Gawde.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be made to a Regulatory Information Service, ensuring market transparency during offer periods.
The UK Takeover Panel’s Market Surveillance Unit remains available for consultation regarding dealing disclosure requirements under the Code.
